Dr. Nadira B. Hamid, MD

Dr. Hamid practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.

Dr. Hamid's NPI, 1184039067, was assigned on June 30, 2014. Dr. Hamid holds Minnesota license 71687.

Dr. Hamid's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.

Dr. Hamid's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Hamid is also affiliated with Cambridge Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Hamid to 3 more hospitals, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamid practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hamid's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Hamid's licenses on file in 2 states: Minnesota and New York.

CMS data shows 1,883 Medicare services from Dr. Hamid across 15 procedure codes in 2024, for 1,351 Medicare patients. Medicare paid $96,430 for them.

CMS counts 1,351 Medicare patients who saw Dr. Hamid in 2024. The largest group is 75 to 84, with 533 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamid's median patient age at 71, with 52% women.

In 2024, Dr. Hamid wrote 503 Medicare Part D claims for 135 patients. 69% of them were for generic drugs. CMS names the drug for 382 of them, across 12 drugs with 11 or more claims each, at $140,636 in total drug cost. In 2023, CMS named 300 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Hamid for performance year 2024, reported as part of a group. Dr. Hamid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hamid as offering telehealth.

Dmand AI links 59 papers to Dr. Hamid, published from 2013 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement and Tricuspid Valve Insufficiency. Dr. Hamid has published most often in JACC Cardiovasc Interv. Dr. Hamid's most frequent co-authors are Paul Sorajja, MD, Torsten Peter Vahl, MD and Rebecca T. Hahn, MD.

Dmand AI links Dr. Hamid to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency and Gastroesophageal Reflux.

CMS Open Payments shows 328 general payments to Dr. Hamid from 16 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 30% of the total. Abbott Laboratories paid the most, $60,956.